Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Has announcements × Fulvestrant × Clear all

Phase

Phase 3 5 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

umbralisib 1 ublituximab 1 relatlimab 1 pembrolizumab 1 palbociclib 1 inavolisib 1 imetelstat 1 Pemetrexed 1 Nivolumab 1 GRN163L peptide 1 Fulvestrant 1 Emapalumab 1 Cisplatin 1 Bendamustine Hydrochloride 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04191499 2026-03-17

INAVO120

Hoffmann-La Roche

Phase 2/3 Active not recruiting

325 enrolled 14 charts 1 FDA

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡